Publications

Division/Center

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis.

Lancet Reg Health Am
Ivama-Brummell AM, Marciniuk FL, Wagner AK, Osorio-de-Castro CGS, Vogler S, Mossialos E, Tavares-de-Andrade CL, Naci H

The Pediatrician Workforce in the United States and China.

Pediatrics
Russ CM, Gao Y, Karpowicz K, Lee S, Stephens TN, Trimm F, Yu H, Jiang F, Palfrey J

The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis.

Prim Care Diabetes
Husin M, Teh XR, Ong SM, Lim YMF, Ang SH, Chan CL, Lim MT, Shanmugam S, Khamis N, Jaafar FSA, Ibrahim NI, Nasir NH, Kusuma D, Wagner AK, Ross-Degnan D, Atun R, Sivasampu S

Snuff burnout and reignite passion in medical students.

Med Educ
Laird-Gion JN, Garabedian LF, Conrad R, Shaffer AC, Witkowski ML, Mateo CM, Jones DS, Hundert E, Kasper J

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway.

JAMA
Shahzad M, Naci H, Wagner AK

Newly approved cancer drugs in China - innovation and clinical benefit.

Nat Rev Clin Oncol
Zhang Y, Wagner AK, Guan X

Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.

JAMA Oncol
Bao Y, Zhang H, Bruera E, Portenoy R, Rosa WE, Reid MC, Wen H

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020

Potential Bias of Instrumental Variable Analysis in Comparative Effectiveness Research for Bariatric Surgery.

JAMA Netw Open
Garabedian LF

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

JAMA Netw Open
Zhang Y, Naci H, Wagner AK, Xu Z, Yang Y, Zhu J, Ji J, Shi L, Guan X

Evaluating Natural Experiments that Impact the Diabetes Epidemic: an Introduction to the NEXT-D3 Network.

Curr Diab Rep
Siegel KR, Ali MK, Ackermann RT, Black B, Huguet N, Kho A, Mangione CM, Nauman E, Ross-Degnan D, Schillinger D, Shi L, Wharam JF, Duru OK

New-onset cancer cases in FDA's Sentinel System: a large distributed system of US electronic healthcare data.

Cancer Epidemiol Biomarkers Prev
Haug NR, Wagner AK, McGlynn KA, Leonard CE, Nguyen MD, Major JM

Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.

J Natl Cancer Inst Monogr
Shih YT, Sabik LM, Stout NK, Halpern MT, Lipscomb J, Ramsey S, Ritzwoller DP

Decline in U.S. Emergency Department admission rates driven by critical pathway conditions, 2006-2014.

Am J Emerg Med
Lin MP, Baker O, Richardson LD, Schuur JD

Do noneconomic damage caps reduce medical malpractice insurance premiums? Evidence from North Carolina

Yu, H; Baker, O

Effects of the Affordable Care Act Medicaid Expansion on the Compensation of New Primary Care Physicians.

Med Care
Ma Y, Armstrong D, Forte GJ, Yu H

Comparison of Ambulatory Health Care Costs and Use Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

JAMA Netw Open
Lewis KH, Argetsinger S, Arterburn DE, Clemenzi J, Zhang F, Kamusiime R, Fernandez A, Ross-Degnan D, Wharam JF

Recent Trends in School-Based Mental Health Services Among Low-Income and Racial and Ethnic Minority Adolescents.

JAMA Pediatr
Wilk AS, Hu JC, Wen H, Cummings JR

Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016.

J Natl Compr Canc Netw
Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK

Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil.

BMJ Glob Health
Ivama-Brummell AM, Wagner AK, Pepe VLE, Naci H